Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
The product is being launched in August 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
This product will be launched through Granules Consumer Health (GCH) division
The company is already marketing the 4 mg and 10 mg strengths
Granules now has a total of 58 ANDA approvals from US FDA
Metoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure.
The product is expected to be launched in June 2023
Subscribe To Our Newsletter & Stay Updated
